The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Curcumin nanoformulations: a future nanomedicine for cancer
Open accessAbstract
Curcumin, a natural diphenolic compound derived from turmeric Curcuma longa, has proven to be a modulator of intracellular signaling pathways that control cancer cell growth, inflammation, invasion, apoptosis and cell death, revealing its anticancer potential. In this review, we focus on the design and development of nanoparticles, self-assemblies, nanogels, liposomes and complex fabrication for sustained and efficient curcumin delivery. We also discuss the anticancer applications and clinical benefits of nanocurcumin formulations. Only a few novel multifunctional and composite nanosystem strategies offer simultaneous therapy as well as imaging characteristics. We also summarize the challenges to developing curcumin delivery platforms and up-to-date solutions for improving curcumin bioavailability and anticancer potential for therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Yadav, V. R., Prasad, S., Kannappan, R., Ravindran, J., Chaturvedi, M. M., Vaahtera, L., Parkkinen, J., & Aggarwal, B. B. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.06.022 · Cited by 148
RetractedBioavailability of curcumin: Problems and promises
Anand, P., Kunnumakkara, A. B., Newman, R. A., & Aggarwal, B. B. (2007) · Molecular Pharmaceutics · doi:10.1021/mp700113r · Cited by 5,543
Targeting multidrug resistance in cancer
Szakács, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C., & Gottesman, M. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1984 · Cited by 3,609
Curcumin as “Curecumin”: From kitchen to clinic
Goel, A., Kunnumakkara, A. B., & Aggarwal, B. B. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.016 · Cited by 2,214
Curcumin: From ancient medicine to current clinical trials
Hatcher, H., Planalp, R., Cho, J., Torti, F. M., & Torti, S. V. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7452-4 · Cited by 1,843
Multiple biological activities of curcumin: A short review
Maheshwari, R. K., Singh, A. K., Gaddipati, J., & Srimal, R. C. (2006) · Life Sciences · doi:10.1016/j.lfs.2005.12.007 · Cited by 1,674
CURCUMIN: THE INDIAN SOLID GOLD
Aggarwal, B. B., Sundaram, C., Malani, N., & Ichikawa, H. (2007) · ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY · doi:10.1007/978-0-387-46401-5_1 · Cited by 1,647
Dose escalation of a curcuminoid formulation
Lao, C. D., Ruffin, M. T., Normolle, D., Heath, D. D., Murray, S. I., Bailey, J. M., Boggs, M. E., Crowell, J., Rock, C. L., & Brenner, D. E. (2006) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-6-10 · Cited by 1,394
Bisht, S., Feldmann, G., Soni, S., Ravi, R., Karikar, C., Maitra, A., & Maitra, A. (2007) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-5-3 · Cited by 1,090
Kunnumakkara, A. B., Anand, P., & Aggarwal, B. B. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.009 · Cited by 1,073
Cited by
Gong, C., Wu, Q., Wang, Y., Zhang, D., Luo, F., Zhao, X., Wei, Y., & Qian, Z. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.05.005 · Cited by 542
Bioavailability enhancers of herbal origin: An overview
Kesarwani, K., & Gupta, R. (2013) · Asian Pacific Journal of Tropical Biomedicine · doi:10.1016/s2221-1691(13)60060-x · Cited by 498
Fuloria, S., Mehta, J., Chandel, A., Sekar, M., Rani, N. N. I. M., Begum, M. Y., Subramaniyan, V., Chidambaram, K., Thangavelu, L., Nordin, R., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.820806 · Cited by 481
Biogenic silver nanoparticles for cancer treatment: An experimental report
Jeyaraj, M., Sathishkumar, G., Sivanandhan, G., MubarakAli, D., Rajesh, M., Arun, R., Kapildev, G., Manickavasagam, M., Thajuddin, N., Premkumar, K., et al. (2013) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2013.01.027 · Cited by 449
Recent advances in selective photothermal therapy of tumor
Zhao, L., Zhang, X., Wang, X., Guan, X., Zhang, W., & Ma, J. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01080-3 · Cited by 445
Metal complexes of curcumin – synthetic strategies, structures and medicinal applications
Wanninger, S., Lorenz, V., Subhan, A., & Edelmann, F. T. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00088b · Cited by 426
Nanocurcumin: A Promising Candidate for Therapeutic Applications
Karthikeyan, A., Senthil, N., & Min, T. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00487 · Cited by 414
Therapeutic Applications of Curcumin Nanoformulations
Yallapu, M. M., Nagesh, P. K. B., Jaggi, M., & Chauhan, S. C. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9811-z · Cited by 392
Self-citationNatural product-based nanomedicine: recent advances and issues
Xu, B., Watkins, R., Wu, L., Zhang, C., & Davis, R. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s92162 · Cited by 375
Yavarpour-Bali, H., Ghasemi-Kasman, M., & Pirzadeh, M. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s208332 · Cited by 364
Chen, F.-P., Li, B.-S., & Tang, C.-H. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b00448 · Cited by 352
Zheng, B., & McClements, D. J. (2020) · Molecules · doi:10.3390/molecules25122791 · Cited by 344
Antibacterial Action of Curcumin against Staphylococcus aureus: A Brief Review
Teow, S.-Y., Liew, K., Ali, S. A., Khoo, A. S.-B., & Peh, S.-C. (2016) · Journal of Tropical Medicine · doi:10.1155/2016/2853045 · Cited by 328
Comparative absorption of curcumin formulations
Jäger, R., Lowery, R. P., Calvanese, A. V., Joy, J. M., Purpura, M., & Wilson, J. M. (2014) · Nutrition Journal · doi:10.1186/1475-2891-13-11 · Cited by 320
Liu, J., Chen, Z., Wang, J., Li, R., Li, T., Chang, M., Yan, F., & Wang, Y. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b03868 · Cited by 306
Curcumin Formulations for Better Bioavailability: What We Learned from Clinical Trials Thus Far?
Hegde, M., Girisa, S., BharathwajChetty, B., Vishwa, R., & Kunnumakkara, A. B. (2023) · ACS Omega · doi:10.1021/acsomega.2c07326 · Cited by 301
Coradini, K., Lima, F. O., Oliveira, C. M., Chaves, P. S., Athayde, M. L., Carvalho, L. M., & Beck, R. C. R. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.04.009 · Cited by 200
Formulations of Curcumin Nanoparticles for Brain Diseases
Del Prado-Audelo, M. L., Caballero-Florán, I. H., Meza-Toledo, J. A., Mendoza-Muñoz, N., González-Torres, M., Florán, B., Cortés, H., & Leyva-Gómez, G. (2019) · Biomolecules · doi:10.3390/biom9020056 · Cited by 191
“This is because they can be designed and adapted to the desired size, chemical composition, surface charge, and surface functionalization, rendering them potent tools for the treatment of specific diseases such as neurodegenerative disorders and cancer [75,76].”
BackgroundAnitha, A., Deepa, N., Chennazhi, K. P., Lakshmanan, V.-K., & Jayakumar, R. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.06.004 · Cited by 158
New Insights toward Colorectal Cancer Chemotherapy Using Natural Bioactive Compounds
Redondo-Blanco, S., Fernández, J., Gutiérrez-del-Río, I., Villar, C. J., & Lombó, F. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00109 · Cited by 113
Chen, L., Wang, Y., Zhang, J., Hao, L., Guo, H., Lou, H., & Zhang, D. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.12.005 · Cited by 78
Walsh, K. H., Das, R. K., Saladin, M. E., & Kamboj, S. K. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4983-8 · Cited by 77
Strojny, B., Grodzik, M., Sawosz, E., Winnicka, A., Kurantowicz, N., Jaworski, S., Kutwin, M., Urbańska, K., Hotowy, A., Wierzbicki, M., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0164637 · Cited by 33
Metadata
- Authors
- Yallapu, M. M., Jaggi, M., & Chauhan, S. C.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2012-01
- Volume
- 17
- Issue
- 1-2
- Pages
- 71-80
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W2082225136
- Cited by
- 751
- References
- 85
- FWCI
- 14.07
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.